Probably Genetic

📣 Probably Genetic is #hiring ! Are you ready to make a meaningful impact in changing the lives of patients living with severe, complex diseases? We are a tight-knit group of hard-working, ambitious problem solvers united by a mission greater than ourselves. We're building an all-star team to bring our vision to life, and we want you to be a part of it! Check out our open roles and apply today.  https://lnkd.in/gz9dffE4 #TechJobs #BiotechJobs #JoinUs #CareerOpportunity

We may be biased, but innovation that allows us to shorten the diagnostic odyssey for rare disease patients consistently deserves the spotlight (and a full house!) Thanks for having us, World Orphan Drug Congress USA! If you missed Lukas' presentation | 𝐇𝐨𝐰 𝐜𝐚𝐧 𝐀𝐈 𝐚𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐞 𝐭𝐡𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐣𝐨𝐮𝐫𝐧𝐞𝐲 𝐟𝐨𝐫 𝐫𝐚𝐫𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬? Comment below and we'll share it with you.

There is no magic bullet, but there is a magic team! Our LLM-based symptom assessment conversion rate (from landing page > form complete) continues to climb! The higher the conversion rate the more patients living with a rare disease we can identify.

🚨 WODC Happy Hour – A Few Spots Left! 🚨 We’re hosting an exclusive happy hour next Wednesday, April 23rd at Trillium Brewery in Boston—right after the World Orphan Drug Congress. Join us for drinks and great conversation around compliance, OIG opinions, sponsored testing programs, and AI in rare disease. Special guest Greg Demske, former Chief Counsel of the OIG, will be joining us for an evening you won’t want to miss.We have just a few spots left! To register and save your place, email: meghan.lancaster@probablygenetic.com See you in Boston! 🍻

We’re excited to announce that our CEO, Lukas Lange, will speak at World Orphan Drug Congress USA in Boston next week. 📅 April 24th, 2025 ⏰ 11:00 AM EST This presentation will illuminate how AI can shorten the diagnostic journey for patients. We have built an AI-powered symptom assessment and genetic testing platform that can shorten or eliminate the diagnostic odyssey, helping our partners identify patients for their critical treatments more efficiently and effectively. Are you attending next week's conference? We'd love to hear from you!

At just 21, Chaz Lucius — a first-round NHL draft pick — made the incredibly tough decision to retire from hockey after being diagnosed with Ehlers-Danlos syndrome (EDS), a hereditary connective tissue disorder. EDS is commonly known to affect joint hypermobility and stability, which can lead to frequent dislocations and sprains. For years, Chaz struggled with injuries that didn’t heal as expected. Now, with answers, he’s finally able to understand why. His story is a powerful reminder of the impact rare genetic conditions can have — and the importance of getting a diagnosis. We're sending support to Chaz and everyone navigating life with EDS. Read the full NYT article here: https://lnkd.in/g2cQ7GHb #ChazLucius #EhlersDanlosSyndrome #DiagnosisMatters #RareButReal

We're significantly reducing the time to diagnose extremely rare conditions at Probably Genetic. How? We've put the right puzzle pieces together.  🧩 Internet: reach patients who are looking for answers online.  🧩 AI: assess a patient's likelihood of having a rare condition using sophisticated machine learning.  🧩 Whole genome sequencing: while not always necessary, whole exome and whole genome sequencing allow us to identify patients previously undiagnosed or misdiagnosed by evaluating large portions of DNA to identify rare or complex genetic causes. During a recent AMA with Technology Networks Lukas Lange dove into how artificial intelligence is transforming precision medicine for rare genetic conditions. In this clip, Lukas highlights what we at Probably Genetic see daily: when you combine the right puzzle pieces, you shorten the diagnostic journey. Are you working on a condition where patients must wait far too long to reach the right diagnosis? We can help.

Don't make mistake us for just a genetic testing company. We're so much more than that. Many prospective partners are still unaware that one of our greatest strengths lies in our ability to reach and engage patients directly. Our unique brand, suite of services, and market position allow us to connect with patients in ways that most healthcare and pharmaceutical companies simply cannot. But let's let the numbers tell the story. We will openly share and contextualize our numbers with industry benchmarks. This week's metric is click-through-rate (CTR) from advertisements. Why CTR? Because every click means a patient is one step closer to taking action. 🎯 Our average CTR is 2.09%. 🚫 The average across ALL industries is .9%. 🚫 The average CTR for healthcare and pharma industries is .83%. Trying to connect with patients? Connect with us. Reference: Wordstream Ad Benchmarks (2024) #RareDisease #RareDiseaseAwareness #PharmaMarketing

Lukas Lange will lead an Ask Me Anything tomorrow with Technology Networks at 8 AM PDT/11 AM EDT. During the AMA, Lukas will dive into how artificial intelligence is transforming precision medicine for rare genetic conditions. Here's a sneak preview of a few questions that may be addressed: ❓ How can machine learning break down barriers and expand access to care for patients with rare disorders, regardless of their geographic, economic, or social backgrounds? ❓ How can AI accelerate research on rare diseases? ❓ How does technology impact the diagnostic odyssey for those with complex genetic conditions? We can't wait to explore how technology is a powerful ally in rare disease research and patient care! If you'd like to attend the event virtually, we've dropped the registration link in comments! 👇

Probably Genetic's patient-focused digital and social content outperforms biopharmaceutical and biotechnology brands by 60% in engagement metrics. Our specialized approach to rare disease and genetic testing content resonates deeply with patient communities seeking answers. When patients encounter content that genuinely reflects their experiences, they engage more deeply and take meaningful action. We partner with innovative pharma organizations to develop:  ✔️ Highly engaging unbranded or co-branded content ✔️  Disease awareness campaigns  ✔️ Treatment and management landscape resources  ✔️ Patient influencer marketing programs ✔️ Authentic storytelling on the diagnostic odyssey and importance of genetic testing 🗣️ Ready to see how Probably Genetic can transform your patient engagement strategy? Contact us today to discuss how our content expertise can support your next growth phase.